戴維醫療(300314.SZ)變更醫療器械生產許可證
格隆匯1月14日丨戴維醫療(300314.SZ)公佈,公司根據相關法規的規定和要求對《醫療器械生產許可證》的有效期限等進行了變更,並於近日取得了由浙江省藥品監督管理局頒發的變更後的《醫療器械生產許可證》。
企業名稱:寧波戴維醫療器械股份有限公司;許可證編號:浙食藥監械生產許20100125號;生產範圍:2002年分類目錄:第Ⅱ類:6826-3-光譜輻射治療儀器,6854-0-其他,6854-6-負壓吸引裝置,6854-7-呼吸設備配件,6856-0-其他;第Ⅲ類:6854-0-其他;2017年分類目錄:第Ⅱ類:09-03-光治療設備,14-15-病人護理防護用品;第Ⅲ類:08-03-急救設備***;有效期限:至2025年01月09日;發證部門:浙江省藥品監督管理局;發證日期:2020年01月10日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.